Pink Elephant Team

Evolving Minds By Pink Elephant

Business EN ↓ 5 episodes

The Evolving Minds Podcast, by Pink Elephant. Insightful conversations with the entrepreneurs, executives, and changemakers shaping the future of mental health and psychedelic medicine. From ambitious startups to established industry leaders, we spotlight the people and ideas behind the next generation of digital health, alternative therapies, and psychedelic ventures. Meet the Minds Changing the Business of Healing

Author

Pink Elephant Team

Episodes

The Psychedelic Accelerator: How Elephant Gate is Funding the Next Generation of Healing 28.04.2026 24:42

In this exclusive interview, Pink Elephant’s Investment Director Natalia Fedulova sits down with Jason Najum to announce the launch of the Elephant Gate Accelerator. With a decade of experience in venture capital across the globe, Natalia discusses why Pink Elephant is focused on essential infrastructure needed to turn psychedelic medicine into a scalable reality. #PsychedelicAccelerator #MentalH...

Building the Future of BIOTECH, with Doug Drysdale, former CEO of Cybin (Helus Pharma) 26.01.2026 33:58

In this exclusive interview, veteran biotech executive Doug Drysdale sits down with Jason Najum from Pink Elephant to discuss the strategy that steered Cybin through the 'biotech winter.' Although Doug stepped down as CEO in September 2025 and the company has since rebranded to Helus Pharma, his insights reveal the critical data-driven decisions that allowed the company to survive and ev...

Where is the REAL Money in Psychedelics? | Opportunities and Hurdles After FDA Approval 19.09.2025 45:14

Go beyond the FDA approval headlines and into the REAL business of psychedelic medicine. While most eyes are on the drug developers, venture capitalist Maria Velkova shares where the smart money is going. The Tabula Rasa Ventures managing partner tells the untold story of the critical infrastructure needed for psychedelics to succeed post-approval, Big Pharma’s recent entry into the space, the mat...

The Psychedelic Gold Rush Is Over? Big Pharma, AI, and Psychedelic Research Inside the NHS 01.09.2025 50:59

Go inside the REAL business of psychedelic medicine. While everyone talks about investment and FDA headlines, George McBride is on the front lines doing the essential work. The Clerkenwell Health co-founder reveals the untold story of navigating psychedelic clinical trials, Big Pharma’s growing interest, public-private partnerships with the NHS, the future of AI in psychedelic clinical trials, and...

Why Psychedelic Startups Hit a Wall? Ronan Levy on Field Trip’s Rise, Ketamine Clinics & What’s Next 26.07.2025 49:36

Today’s guest is Ronan Levy, co-founder and former CEO of Field Trip Health, joins Jason Najum to reflect on the explosive rise and collapse of one of the first public psychedelic therapy companies. #PsychedelicStartups #KetamineClinics #mentalhealthinnovation #mentalhealthpodcast In this raw and insightful conversation, Ronan shares: - How Field Trip raised $100M and listed on the NASDAQ - Why...